Dr. Taoufik Alsaadi is a Chief Medical Officer and the Chair of the Neurology Department at the American Center of Psychiatry & Neurology (ACPN). He was trained in Epilepsy and Clinical Neurophysiology at the University of California San Francisco and was a research fellow in epilepsy there. He is board-certified by the American Board of Psychiatry and Neurology and by the American Board of Clinical Neurophysiology and by the American Board of Neurology in Clinical Epilepsy.
Before joining ACPN Dr. Alsaadi was the Chief of the Neurology Department at Sheikh Khalifa Medical City for 11 years. He was previously an Associate Professor of Neurology and the Director of the Adult Epilepsy Program and the Clinical Research Program at the University of California Davis. His research has focused on conducting drug study trials for new anti-epileptic agents for patients with epilepsy quality of life in patients with epileptic and non-epileptic disorders as well as other chronic neurological disorders neuropsychiatric co-morbidities with various neurological disorders neuroimaging and electroencephalographic predictors of outcome from epilepsy surgery. He also has a special interest in utilizing various neuroimaging techniques in studying seizure disorders particularly MR spectroscopy and fMRI. Dr. Alsaadi has been honored with several prestigious awards for his work in the field of epilepsy. He has served on the Advisory Board of the Northern California Epilepsy Foundation and on the membership committee of the American Epilepsy Society. He has served as the President of the Western Clinical Neurophysiology Society in the United Sates. He is currently the President of the Emirati League against epilepsy. He also serves at the Editorial Board for BMC Journal of Neurology and Journal of Neurosciences. He has authored and co-authored more than 50 papers and book chapters and has served as a peer-reviewer for more than 15 scientific journals.